account_balance
Investment manager · 13F filer · SEC CIK 2106181
Kalehua Capital Management LLC
Reported value$140Mas of Jun 30, 2026
Positions23 7 new, 7 sold out
Top 10 weight73.9%MANE alone is 13%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
MANEVeradermics Inc
12.8%Added +42%
XFORX4 Pharmaceuticals Inc
12.5%
CMPSCompass Pathways PLC
8.3%
SRZNSurrozen Inc
7.2%
ACRSAclaris Therapeutics Inc
6.9%Added +37%
SIONSionna Therapeutics Inc
6.2%
IKTInhibikase Therapeutics Inc
5.6%Added +43%
PHVSPharvaris NV
4.9%
KPTIKaryopharm Therapeutics Inc
4.8%New
SEPNSepterna Inc
4.7%
IFRXInflarx NV
4.7%New
CYCNCyclerion Therapeutics Inc
4.0%New
MANEVeradermics Inc
12.8%Added +42%
XFORX4 Pharmaceuticals Inc
12.5%
CMPSCompass Pathways PLC
8.3%
SRZNSurrozen Inc
7.2%
ACRSAclaris Therapeutics Inc
6.9%Added +37%
SION6.2%IKT5.6%PHVS4.9%KPTI4.8%SEPN4.7%IFRX4.7%CYCN4.0%
Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
MANE Veradermics Inc 12.8% Added +42%XFOR X4 Pharmaceuticals Inc 12.5% HeldCMPS Compass Pathways PLC 8.3% HeldSRZN Surrozen Inc 7.2% HeldACRS Aclaris Therapeutics Inc 6.9% Added +37%SION Sionna Therapeutics Inc 6.2% HeldIKT Inhibikase Therapeutics Inc 5.6% Added +43%PHVS Pharvaris NV 4.9% HeldKPTI Karyopharm Therapeutics Inc 4.8% NewSEPN Septerna Inc 4.7% HeldIFRX Inflarx NV 4.7% New
CYCN Cyclerion Therapeutics Inc 4.0% New
What changed